Superficially growing basal cell cancer's light activation treatment: comparing three light sensitising creams
- Conditions
- Superficial basal cell carcinomaTherapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2014-002746-50-FI
- Lead Sponsor
- Mari Salmivuori
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Clinically assessed superficial basal cell carcinomas are accepted.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 80
Exclusion Criteria
From the study is excluded clinically pigmented, morpheaphormic, infiltrative, nodular basal cell carcinomas and also basal cell carcinomas which are in the face because there is a difference in thickness of the skin. No pregnant or breast feeding are included.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method